Successful treatment of Candida krusei fungemia with amphotericin B and caspofungin

Medical Mycology

Volumn 44, Issue 7, 2006, Pages 655-657

  Olver, W J ^a   Scott, F ^a   Shankland, G S ^b  

^a NINEWELLS HOSPITAL   (United Kingdom)

^b Specialist Mycology Laboratory   (United Kingdom)

Author keywords

Antifungal therapy; Candida krusei; Fungal infections; Leukemia

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; GRANULOCYTE COLONY STIMULATING FACTOR; TEICOPLANIN; VORICONAZOLE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BLOOD CULTURE; BONE MARROW TRANSPLANTATION; CANDIDA KRUSEI; CANDIDIASIS; CASE REPORT; CLINICAL FEATURE; DRUG SENSITIVITY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; FUNGEMIA; FUNGUS CULTURE; FUNGUS ISOLATION; HOSPITAL ADMISSION; HUMAN; MACULOPAPULAR RASH; MALE; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; NEUTROPENIA; NEUTROPHIL COUNT; TREATMENT OUTCOME;

ADULT; AMPHOTERICIN B; CANDIDA; CANDIDIASIS; DRUG THERAPY, COMBINATION; FUNGEMIA; HUMANS; LEUKEMIA; MALE; PEPTIDES, CYCLIC; TREATMENT OUTCOME;

ISSATCHENKIA ORIENTALIS;

EID: 33750472315     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780600686929     Document Type: Article

References (14)

1. Kibbler, CC and Seaton, S and Barnes, RA and (2003) Management and outcome of bloodstream infections due to Candida species in England and Wales J Hosp Infect, 54, pp. 18-24.
2. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A2, 2nd edn. NCCLS, VillanovaPA, USA, 2002.
3. Wingard, JR and Merz, WG and Rinaldi, MG and (1991) Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole N Engl J Med, 325, pp. 1274-1277.
4. Hoy JF. Flucytosine. In: Kucers A, Crowe SM, Grayson ML, Hoy JF, editors. The Use of Antibiotics. 5th edn. pp 1304-1316.
5. Pfaller, MA and Messer, SA and Boyken, L and (2002) In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods Antimicrob Agents Chemother, 46, pp. 3518-3521.
6. Pfaller, MA and Messer, SA and Boyken, L and (2003) Caspofungin activity against clinical isolates of fluconazole-resistant Candida J Clin Microbiol, 41, pp. 5729-5731.
7. Mora-Duarte, J and Betts, R and Rotstein, C and (2002) Caspofungin Invasive Candidiasis Study Group. Comparison of caspofungin and amphotericin B for invasive candidiasis N Engl J Med, 347, pp. 2020-2029.
8. Canton, E and Peman, J and Gobernado, M and Viudes, A and Espinel-Ingroff, A. (2004) Patterns of amphotericin B killing kinetics against seven Candida species Antimicrob Agents Chemother, 48, pp. 2477-2482.
9. Nivoix, Y and Zamfir, A and Lutun, P and (2006) Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections J Infect, 52, pp. 67-74.
10. Sora, F and Chiusolo, P and Piccirillo, N and (2002) Successful treatment with caspofungin of hepatosplenic candidiasis resistant to liposomal amphotericin B Clin Infect Dis, 35, pp. 1135.
11. McGee, WT and Tereso, GJ. (2003) Successful treatment of Candida krusei infection with caspofungin acetate: A new antifungal agent Crit Care Med, 31, pp. 1577-1578.
12. Hossain, MA and Reyes, GH and Long, LA and Mukherjee, PK and Ghannoum, MA. (2003) Efficacy of caspofungin combined with amphotericin B against azole-resistant Candida albicans J Antimicrob Chemother, 51, pp. 1427-1429.
13. Flattery AM, Bartizal K, Gill CJ,. Preclinical efficacy of MK-991 in combination with amphotericin B or fluconazole in mouse models of disseminated aspergillosis, candidiasis and cryptococcosis. In Program and Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1998. Abstract J-61, p.468. American Society for Microbiology, Washington DCUSA.
14. Pelletier, R and Alarie, I and Lagace, R and Walsh, TJ. (2005) Emergence of disseminated candidiasis caused by Candida krusei during treatment with caspofungin: Case report and review of literature Med Mycol, 43, pp. 559-564.